Kristen Ambrose is SVP & Chief Accounting Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 7,500 shares of VRTX, which is worth approximately $3.06 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 240 shares (Common Stock) at a price of $419.0 per share, resulting in proceeds of $100,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.5K
0% 3M change
9.68% 12M change
Total Value Held $3.06 Million

Kristen Ambrose Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
SELL
Open market or private sale
$100,560 $419.0 p/Share
240 Reduced 3.1%
7,500 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$94,072 $418.1 p/Share
225 Reduced 2.82%
7,740 Common Stock
Feb 26 2024
SELL
Open market or private sale
$375,893 $425.7 p/Share
883 Reduced 9.98%
7,965 Common Stock
Feb 23 2024
SELL
Payment of exercise price or tax liability
$357,522 $431.79 p/Share
828 Reduced 8.56%
8,848 Common Stock
Feb 12 2024
SELL
Open market or private sale
$577,409 $420.24 p/Share
1,374 Reduced 12.43%
9,676 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$249,839 $422.74 p/Share
591 Reduced 5.08%
11,050 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
1,853 Added 13.73%
11,641 Common Stock
Feb 06 2024
BUY
Grant, award, or other acquisition
-
2,950 Added 23.16%
9,788 Common Stock
May 30 2023
SELL
Open market or private sale
$95,317 $329.82 p/Share
289 Reduced 4.06%
6,838 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$55,218 $313.74 p/Share
176 Reduced 2.41%
7,127 Common Stock
Feb 27 2023
SELL
Open market or private sale
$348,243 $288.52 p/Share
1,207 Reduced 14.18%
7,303 Common Stock
Feb 24 2023
SELL
Payment of exercise price or tax liability
$145,138 $289.12 p/Share
502 Reduced 5.57%
8,510 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
5,516 Added 37.97%
9,012 Common Stock
Apr 25 2022
SELL
Open market or private sale
$88,045 $269.25 p/Share
327 Reduced 8.55%
3,496 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$36,043 $263.09 p/Share
137 Reduced 3.46%
3,823 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
2,566 Added 39.32%
3,960 Common Stock
KA

Kristen Ambrose

SVP & Chief Accounting Officer
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX